Cargando…

Hematologic malignancies following immune checkpoint inhibition for solid tumors

Immune checkpoint inhibition (ICI) can induce durable responses in patients with advanced malignancies. Three cases of hematological neoplasia following ICI for solid tumors have been reported to date. We present five patients treated at our tertiary referral center between 2017 and 2021 who develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Eijs, Mick J. M., van der Wagen, Lotte E., Mous, Rogier, Leguit, Roos J., van de Corput, Lisette, van Lindert, Anne S. R., Suelmann, Britt B. M., Kamphuis, Anna M., Nierkens, Stefan, Suijkerbuijk, Karijn P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188911/ https://www.ncbi.nlm.nih.gov/pubmed/35691988 http://dx.doi.org/10.1007/s00262-022-03230-4

Ejemplares similares

Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance
por: Verheijden, Rik J., et al.
Publicado: (2023)

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis
por: van Eijs, Mick J.M., et al.
Publicado: (2023)

Added diagnostic value of routinely measured hematology variables in diagnosing immune checkpoint inhibitor mediated toxicity in the emergency department
por: Niemantsverdriet, Michael S. A., et al.
Publicado: (2023)

Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab
por: Tonk, Erwin H.J., et al.
Publicado: (2019)

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review
por: Hommes, Josefien W., et al.
Publicado: (2021)

Frailty and checkpoint inhibitor toxicity in older patients with melanoma
por: Bruijnen, Cheryl P., et al.
Publicado: (2022)

Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Nipple Aspirate Fluid at a Glance
por: Patuleia, Susana I. S., et al.
Publicado: (2021)

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
por: Cornel, Annelisa M., et al.
Publicado: (2018)

A Minimal Parameter Set Facilitating Early Decision-making in the Diagnosis of Hemophagocytic Lymphohistiocytosis
por: Smits, Bas M., et al.
Publicado: (2021)

Checkpoint inhibition in hematologic malignancies
por: Tsumura, Aaron, et al.
Publicado: (2023)

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease
por: Verheijden, Rik J, et al.
Publicado: (2020)

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
por: Biewenga, Maaike, et al.
Publicado: (2021)

Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study
por: Koks, Marije S., et al.
Publicado: (2021)

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study
por: van der Kooij, Monique K., et al.
Publicado: (2021)

Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation
por: Litjens, Nicolle H. R., et al.
Publicado: (2018)

The use of red flags during the referral chain of patients surgically treated for symptomatic spinal metastases
por: van Tol, Floris R, et al.
Publicado: (2023)

Checkpoint inhibitors in hematological malignancies
por: Ok, Chi Young, et al.
Publicado: (2017)

Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation
por: van Eijs, Mick J. M., et al.
Publicado: (2017)

Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016
por: Tzankov, Alexandar, et al.
Publicado: (2018)

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
por: van Not, Olivier J., et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and Adjust
por: de Witte, Moniek, et al.
Publicado: (2021)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Diagnostic pitfalls after COVID-19 vaccination in melanoma and breast cancer patients: A case series
por: de Bock, Ellen, et al.
Publicado: (2022)

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
por: Schouwenburg, Maartje G., et al.
Publicado: (2019)

Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors
por: Lo Presti, Vania, et al.
Publicado: (2020)

Milk as a Source of Infection
por: Corput, G. M.
Publicado: (1897)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection
por: de Groot, Jolien S., et al.
Publicado: (2016)

Hematologic Complications of Immune Checkpoint Inhibitors
por: Davis, Elizabeth J., et al.
Publicado: (2019)

Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020)

Hematologic complications of immune checkpoint inhibitors
por: Kroll, Michael H., et al.
Publicado: (2022)

Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study – a multicentre prospective observational cohort study
por: Janssen, Liselore M, et al.
Publicado: (2022)

Clinical Biochemistry and Hematology
por: Washington, Ida M., et al.
Publicado: (2012)

Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
por: Patuleia, Susana I. S., et al.
Publicado: (2022)

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
por: Schuiveling, M., et al.
Publicado: (2020)

Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands
por: Flach, Rachel N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5o0g31bbb5mdh92pr3npdmi8f